Nucleosyn
  • Home
  • Products
    • All products
    • Products categories
    • DNA-RNA
    • Synthetic lipids
    • Stable isotope
    • Custom chemical synthesis
  • Capabilities
  • About Us
  • Contact
  • Linkedin

My selection

Catalog

Products

Nucleosyn offers an extensive line of standard phosphoramidites, RNA phosphoramidites, specialty amidites and modifiers, solid supports CPG, reagents and solvents for a wide variety of instruments.

Categories:
DNA-RNA
Synthetic lipids
Stable isotope
Custom synthesis services
Search / Filtering
Tags
Filters changed, please click to submit when done
Page 3 of 19
  • [13C6]-Paclitaxel

    -Paclitaxel Image 1
    Stable isotope

    Paclitaxel is a chemotherapy medication used to treat various cancers, including ovarian cancer, esophageal cancer, br...

    Add to my selection

    More infos
    Anticancer drugTherapeutic Drug Monitoring (TDM)SIL
    More tags Less tags
  • [D5]-Paclitaxel

    -Paclitaxel Image 1
    Stable isotope

    Paclitaxel is a chemotherapy medication used to treat various cancers, including ovarian cancer, esophageal cancer, br...

    Add to my selection

    More infos
    Anticancer drugTherapeutic Drug Monitoring (TDM)SIL
    More tags Less tags
  • [13CD3]-Sorafenib

    -Sorafenib Image 1
    Stable isotope

    Sorafenib is a kinase inhibitor used to treat primary kidney cancer (renal cell carcinoma), advanced primary liver can...

    Add to my selection

    More infos
    Anticancer drugTherapeutic Drug Monitoring (TDM)SIL
    More tags Less tags
  • [D5]-Tamoxifen

    -Tamoxifen Image 1
    Stable isotope

    Tamoxifen is a selective estrogen receptor modulator used to prevent breast cancer for both women and men. Studies are...

    Add to my selection

    More infos
    Anticancer drugTherapeutic Drug Monitoring (TDM)SIL
    More tags Less tags
  • [D4]-Cyclophosphamide

    -Cyclophosphamide Image 1
    Stable isotope

    Cyclophosphamide is an immunosuppressive drug used to treat various types of cancers and diseases, including lymphoma,...

    Add to my selection

    More infos
    Anticancer drugTherapeutic Drug Monitoring (TDM)SIL
    More tags Less tags
  • [D4]-Lurbinectedin

    -Lurbinectedin Image 1
    Stable isotope

    Lurbinectedin is a synthetic alkaloid analog used to treat small-cell lung cancer (SCLC). This drug induces numerous s...

    Add to my selection

    More infos
    Anticancer drugTherapeutic Drug Monitoring (TDM)SIL
    More tags Less tags
  • [D3]-Trabectedin

    -Trabectedin Image 1
    Stable isotope

    Trabectedin is an alkaloid anticancer drug used to treat advanced soft-tissue sarcoma and ovarian cancer. It is indica...

    Add to my selection

    More infos
    Anticancer drugTherapeutic Drug Monitoring (TDM)SIL
    More tags Less tags
  • [13C5]-Azacytidine

    -Azacytidine Image 1
    Stable isotope

    Azacytidine is a chemical analog of cytidine which is used to treat myelodysplastic syndrome (MDS), myeloid leukemia, ...

    Add to my selection

    More infos
    Anticancer drugTherapeutic Drug Monitoring (TDM)SIL
    More tags Less tags
  • [D11]-Capecitabine

    -Capecitabine Image 1
    Stable isotope

    Capecitabine is an anticancer drug used to treat breast cancer (advanced or metastatic), gastric cancer (unresectable ...

    Add to my selection

    More infos
    Anticancer drugTherapeutic Drug Monitoring (TDM)SIL
    More tags Less tags
  • [13C,15N2]-5’-Deoxy-5-fluorocytidine

    -5’-Deoxy-5-fluorocytidine Image 1
    Stable isotope

    5’-Deoxy-5-fluorocytidine is an intermediate metabolite of Capecitabine. Capecitabine is converted by carboxylestera...

    Add to my selection

    More infos
    Anticancer drugTherapeutic Drug Monitoring (TDM)SIL
    More tags Less tags
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10

logo footerNucleosyn

111 Bd Duhamel du Monceau

45160 Olivet

Products

See Catalog

Know more about products

Contact

Contact Form

+33 2 38 49 45 73

Follow us

Other Infos

Legal notices

Privacy Policy & cookies infos

General terms & conditions

© Nucleosyn 2026 - All rights reserved

Design and development Think Ad Communication